Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 66Active not recruiting 15Recruiting 10Terminated 7Unknown 4Withdrawn 3Not yet recruiting 1

Sponsor Class

OTHER 122NIH 22INDUSTRY 9NETWORK 4OTHER_GOV 3

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 3Gastrointestinal 1

Conditions

Multiple Myeloma 2Immunoglobulin Light-chain Amyloidosis 1Colorectal Neoplasms 1Amyloidosis 1

Interventions

Cisplatin 15Paclitaxel 14Taxes 10Cyclophosphamide 9Carboplatin 9Gemcitabine 7Platinum 61,2-diaminocyclohexaneplatinum II citrate 6Trastuzumab 5Radiotherapy 5Oxaliplatin 5Doxorubicin 5Docetaxel 5Cytarabine 5Capecitabine 5Brachytherapy 5fludarabine 4Rituximab 4Radiosurgery 4Fluorouracil 4Dexamethasone 4Watchful Waiting 3Radiotherapy, Intensity-Modulated 3Pemetrexed 3Nimorazole 3Lenalidomide 3Imatinib Mesylate 3Idarubicin 3Gene Expression Profiling 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × NETWORK × Dexamethasone × Clear all
NCT06189833 2024-04-23

TAURUS

European Myeloma Network B.V.

Phase 2 Unknown
200 enrolled
Plasma cell

Multiple Myeloma

NCT05066607 2024-03-06

IsAMYP

Intergroupe Francophone du Myelome

Phase 2 Unknown
46 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT03626922 2022-06-10

Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients

NSABP Foundation Inc

Phase 1 Unknown
33 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01532856 2012-02-15

Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years

Grupo de Estudos Multicentricos em Onco-Hematologia

Phase 3 Unknown
64 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡